Fund Holdings — Foresite Capital Management IV, LLC

Total Portfolio Value:
$252.03M
Total Bought:
$9.21M
Total Sold:
$5.61M
Net Transaction:
+$3.60M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Pharvaris N.V.
COM
4,778,5814,778,5810$165.24M$151.58M60.14%-$13.67M
Cytokinetics, Incorporated(CYTK)714,695714,6950$60.88M$47.11M18.69%-$13.78M
Relay Therapeutics, Inc.(RLAY)1,250,0001,250,0000$23.39M$22.56M8.95%-$825.0K
Eikon Therapeutics, Inc.(EIKN)1,943,6821,943,6820$25.37M$15.63M6.20%-$9.74M
Veracyte, Inc.(VCYT)0200,000+200,000$0$9.21M3.65%+$9.21M
Xenon Pharmaceuticals Inc.(XENE)160,000160,0000$9.66M$5.95M2.36%-$3.71M
Crinetics Pharmaceuticals, Inc.150,0000-150,000$5.61M$0—-$5.61M
Page 1 of 1
Foresite Capital Management IV, LLC — 13F Holdings — Q3 2026 | TickerTrail